Lourenco Costa Michael's Insider Trades & SAST Disclosures
Lourenco Costa Michael's most recent trade in Sabra Healthcare REIT Inc was a trade of 3,858 Common Stock done . Disclosure was reported to the exchange on Feb. 28, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Lourenco Costa Michael.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sabra Healthcare REIT Inc | Michael Lourenco Costa | Executive VP, CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 3,858 | 344,613 (0%) | 0% | 0 | Common Stock | |
| Sabra Healthcare REIT Inc | Michael Lourenco Costa | Executive VP, CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 63,782 | 340,755 (0%) | 0% | 0 | Common Stock | |
| Sabra Healthcare REIT Inc | Michael Lourenco Costa | Executive VP, CFO & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.18 per share. | 08 Jan 2025 | 15,783 | 276,973 (0%) | 0% | 17.2 | 271,152 | Common Stock |
| Sabra Healthcare REIT Inc | Costa Lourenco Michael | Executive VP, CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2024 | 37,477 | 292,756 (0%) | 0% | 0 | Common Stock | |
| Sabra Healthcare REIT Inc | Lourenco Costa Michael | Executive VP, CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Nov 2024 | 2,429 | 255,279 (0%) | 0% | 0 | Common Stock | |
| Sabra Healthcare REIT Inc | Michael Lourenco Costa | Executive VP, CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Aug 2024 | 2,624 | 252,850 (0%) | 0% | 0 | Common Stock | |
| Sabra Healthcare REIT Inc | Michael Lourenco Costa | Executive VP, CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 3,004 | 250,226 (0%) | 0% | 0 | Common Stock | |
| Sabra Healthcare REIT Inc | Michael Lourenco Costa | Executive VP, CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 3,089 | 247,222 (0%) | 0% | 0 | Common Stock | |
| Sabra Healthcare REIT Inc | Michael Costa Lourenco | Executive VP, CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 23,209 | 244,133 (0%) | 0% | 0 | Common Stock | |
| Sabra Healthcare REIT Inc | Costa Lourenco Michael | Executive VP, CFO & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.64 per share. | 05 Jan 2024 | 468 | 220,924 (0%) | 0% | 13.6 | 6,384 | Common Stock |
| Sabra Healthcare REIT Inc | Michael Costa Lourenco | Executive VP, CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Dec 2023 | 36,468 | 221,392 (0%) | 0% | 0 | Common Stock | |
| Sabra Healthcare REIT Inc | Lourenco Michael Costa | Executive VP, CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2023 | 1,706 | 184,924 (0%) | 0% | 0 | Common Stock | |
| Sabra Healthcare REIT Inc | Michael Lourenco Costa | Executive VP, CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 2,103 | 179,329 (0%) | 0% | 0 | Common Stock | |
| Sabra Healthcare REIT Inc | Michael Lourenco Costa | Executive VP, CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 14,894 | 182,377 (0%) | 0% | 0 | Common Stock | |
| Sabra Healthcare REIT Inc | Michael Lourenco Costa | Executive VP, CFO & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.80 per share. | 28 Feb 2023 | 5,151 | 177,226 (0%) | 0% | 11.8 | 60,782 | Common Stock |
| Sabra Healthcare REIT Inc | Michael Lourenco Costa | Executive VP, CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 1,939 | 167,483 (0%) | 0% | 0 | Common Stock | |
| Sabra Healthcare REIT Inc | Michael Lourenco Costa | Executive VP, CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2023 | 4,437 | 167,076 (0%) | 0% | 0 | Common Stock | |
| Sabra Healthcare REIT Inc | Michael Lourenco Costa | Executive VP, CFO & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.46 per share. | 28 Jan 2023 | 1,532 | 165,544 (0%) | 0% | 13.5 | 20,621 | Common Stock |
| Sabra Healthcare REIT Inc | Michael Lourenco Costa | Executive VP, CFO & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.10 per share. | 04 Jan 2023 | 1,008 | 162,639 (0%) | 0% | 13.1 | 13,205 | Common Stock |
| Sabra Healthcare REIT Inc | Michael Lourenco Costa | Executive VP, CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2022 | 34,777 | 163,647 (0%) | 0% | 0 | Common Stock | |
| Sabra Healthcare REIT Inc | Michael Lourenco Costa | Executive VP, CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 1,016 | 128,870 (0%) | 0% | 0 | Common Stock | |
| Sabra Healthcare REIT Inc | Michael Lourenco Costa | Executive VP, CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2022 | 859 | 127,854 (0%) | 0% | 0 | Common Stock | |
| Sabra Healthcare REIT Inc | Michael Lourenco Costa | Executive VP, CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 897 | 126,995 (0%) | 0% | 0 | Common Stock | |
| Sabra Healthcare REIT Inc | Michael Lourenco Costa | Executive VP, CFO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 916 | 126,098 (0%) | 0% | 0 | Common Stock | |
| Sabra Healthcare REIT Inc | Michael Lourenco Costa | Executive VP & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Dec 2021 | 24,696 | 126,507 (0%) | 0% | 0 | Common Stock | |
| Sabra Healthcare REIT Inc | Michael Lourenco Costa | Executive VP & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 444 | 101,811 (0%) | 0% | 0 | Common Stock | |
| Sabra Healthcare REIT Inc | Michael Lourenco Costa | Executive VP & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2021 | 353 | 101,367 (0%) | 0% | 0 | Common Stock | |
| Sabra Healthcare REIT Inc | Michael Lourenco Costa | Executive VP & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 315 | 101,014 (0%) | 0% | 0 | Common Stock | |
| Sabra Healthcare REIT Inc | Michael Lourenco Costa | Executive VP & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 316 | 95,409 (0%) | 0% | 0 | Common Stock | |
| Sabra Healthcare REIT Inc | Michael Lourenco Costa | Executive VP & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2021 | 5,988 | 97,339 (0%) | 0% | 0 | Common Stock | |
| Sabra Healthcare REIT Inc | Michael Lourenco Costa | Executive VP & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.20 per share. | 13 Jan 2021 | 2,246 | 95,093 (0%) | 0% | 17.2 | 38,631 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges